Physician profile
Paul E Turer
NPI 1922006287
$3,169.00
in general payments reported to CMS, 2019-2025
6 companies · $2.03 in 2025
The $2.03 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2021: $2,438 · 2023: $128 · 2024: $288 · 2025: $2.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $369 · Education: $48.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $368.87 |
| Education | $48.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akebia Therapeutics INC | $2,554.07 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $242.16 | 2019-2024 | Lokelma |
| Amgen INC. | $220.82 | 2019-2024 | Tavneos |
| Baxter Healthcare | $76.92 | 2019 | |
| Travere Therapeutics, INC. | $48.78 | 2023-2025 | Filspari |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.25 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Turer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.